BR9606648B1 - produto de combinaÇço, composiÇço farmacÊutica e medicamento. - Google Patents

produto de combinaÇço, composiÇço farmacÊutica e medicamento.

Info

Publication number
BR9606648B1
BR9606648B1 BRPI9606648-2A BR9606648A BR9606648B1 BR 9606648 B1 BR9606648 B1 BR 9606648B1 BR 9606648 A BR9606648 A BR 9606648A BR 9606648 B1 BR9606648 B1 BR 9606648B1
Authority
BR
Brazil
Prior art keywords
medicament
pharmaceutical composition
combination product
receptors
cells
Prior art date
Application number
BRPI9606648-2A
Other languages
English (en)
Other versions
BR9606648A (pt
Inventor
Serge Michel
Veronique Dionisius-Pouget
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9482603&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9606648(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of BR9606648A publication Critical patent/BR9606648A/pt
Publication of BR9606648B1 publication Critical patent/BR9606648B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
BRPI9606648-2A 1995-09-15 1996-09-10 produto de combinaÇço, composiÇço farmacÊutica e medicamento. BR9606648B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9510854A FR2738745B1 (fr) 1995-09-15 1995-09-15 Nouvelles compositions a base d'un melange synergetique entre au moins un ligand de vdr et un retinoide, et leurs utilisations
PCT/FR1996/001386 WO1997009987A1 (fr) 1995-09-15 1996-09-10 Nouvelles compositions a base d'un melange synergetique entre au moins un ligand de vdr et un retinoide

Publications (2)

Publication Number Publication Date
BR9606648A BR9606648A (pt) 1997-09-16
BR9606648B1 true BR9606648B1 (pt) 2009-01-13

Family

ID=9482603

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9606648-2A BR9606648B1 (pt) 1995-09-15 1996-09-10 produto de combinaÇço, composiÇço farmacÊutica e medicamento.

Country Status (14)

Country Link
US (1) US6759396B1 (pt)
EP (1) EP0788361B1 (pt)
JP (1) JP2898100B2 (pt)
AT (1) ATE218349T1 (pt)
AU (1) AU687687B2 (pt)
BR (1) BR9606648B1 (pt)
CA (1) CA2204437C (pt)
DE (1) DE69621580T2 (pt)
DK (1) DK0788361T3 (pt)
ES (1) ES2181908T3 (pt)
FR (1) FR2738745B1 (pt)
NZ (1) NZ318430A (pt)
PT (1) PT788361E (pt)
WO (1) WO1997009987A1 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6538037B2 (en) * 1991-01-08 2003-03-25 Bone Care International, Inc. Methods for preparation and use of 1α,24(S)-dihydroxyvitamin D2
US20010002396A1 (en) 1998-07-16 2001-05-31 Charles Achkar Compositions and methods of treating skin conditions
US6552009B2 (en) 1998-07-16 2003-04-22 Gentrix Llc Compositions and methods of treating abnormal cell proliferation
FR2804323B1 (fr) * 2000-01-31 2006-07-07 Galderma Res & Dev Utilisation de composes de type retinoides en tant qu'agents anti-bacteriens
DE10255861A1 (de) * 2002-11-29 2004-06-17 Axxima Pharmaceuticals Ag Gegen Hepatitis C-Virusinfektionen nützliche Verbindungen und Substanzen
JP4473491B2 (ja) * 2002-05-28 2010-06-02 株式会社資生堂 毛穴縮小剤
EP1687258A2 (en) * 2003-11-20 2006-08-09 Eli Lilly And Company Vitamin d receptor modulators
CA2544517A1 (en) * 2003-11-20 2005-06-09 Eli Lilly And Company Vitamin d receptor modulators
WO2005102296A2 (en) * 2004-04-23 2005-11-03 Heptagen Limited Combinations for the treatment of immunoproliferative skin disorders such as psoriasis
AU2005253735A1 (en) * 2004-06-17 2005-12-29 Galderma S.A. Composition for the treatment of psoriasis comprising a silicone agent, a corticosteroid and vitamin D or a derivative thereof
BRPI0511387A (pt) * 2004-06-17 2007-12-04 Galderma Sa composição e seu uso
CA2567683A1 (en) * 2004-06-17 2005-12-29 Galderma S.A. Composition in spray form comprising a combination of a corticoid and a vitamin d derivative in an oily phase
FR2871695B1 (fr) * 2004-06-17 2008-07-04 Galderma Sa Composition pharmaceutique comprenant un agent silicone et deux principes actifs solubilises
FR2871698B1 (fr) * 2004-06-17 2008-07-04 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques et une phase huileuse
FR2871700B1 (fr) * 2004-06-17 2006-11-17 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, et une phase huileuse
WO2006133829A2 (de) * 2005-06-17 2006-12-21 Dsm Ip Assets B.V. Verwendung von 25-hydroxy-vitamin d3
US20100056644A1 (en) * 2006-11-29 2010-03-04 Nilendu Sen Pharmaceutical compositions containing anhydrous calcipotriene
CN103202821B (zh) * 2013-04-09 2014-10-01 青岛正大海尔制药有限公司 一种骨化三醇软胶囊及其制备方法
CN113577050A (zh) 2015-10-30 2021-11-02 亭铂医药有限责任公司 异维甲酸制剂及其用途和方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU85849A1 (fr) * 1985-04-11 1986-11-05 Cird Derives benzonaphtaleniques,leur procede de preparation et leur application dans les domaines pharmaceutiques et cosmetiques
US5780676A (en) * 1992-04-22 1998-07-14 Ligand Pharmaceuticals Incorporated Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors
FR2713640B1 (fr) * 1993-12-15 1996-01-05 Cird Galderma Nouveaux composés aromatiques polycycliques, compositions pharmaceutiques et cosmétiques les contenant et utilisations.
FR2713635B1 (fr) 1993-12-15 1996-01-05 Cird Galderma Nouveaux composés propynyl bi-aromatiques, compositions pharmaceutiques et cosmétiques les contenant et utilisations.
FR2733684B1 (fr) * 1995-05-03 1997-05-30 Cird Galderma Utilisation de retinoides dans une composition cosmetique ou pour la fabrication d'une composition pharmaceutique

Also Published As

Publication number Publication date
CA2204437C (fr) 2003-06-10
ES2181908T3 (es) 2003-03-01
FR2738745A1 (fr) 1997-03-21
EP0788361A1 (fr) 1997-08-13
DE69621580T2 (de) 2003-03-13
JP2898100B2 (ja) 1999-05-31
JPH10503533A (ja) 1998-03-31
FR2738745B1 (fr) 1997-10-24
PT788361E (pt) 2002-11-29
BR9606648A (pt) 1997-09-16
WO1997009987A1 (fr) 1997-03-20
NZ318430A (en) 2000-09-29
EP0788361B1 (fr) 2002-06-05
ATE218349T1 (de) 2002-06-15
DE69621580D1 (de) 2002-07-11
AU6991296A (en) 1997-04-01
DK0788361T3 (da) 2002-07-15
CA2204437A1 (fr) 1997-03-20
MX9703461A (es) 1997-07-31
AU687687B2 (en) 1998-02-26
US6759396B1 (en) 2004-07-06

Similar Documents

Publication Publication Date Title
BR9606648B1 (pt) produto de combinaÇço, composiÇço farmacÊutica e medicamento.
FI102142B (fi) Kosmeettinen koostumus, joka käsittää vähintään yhtä aktiivista ainett a sisältäviä, polymeerista tai rasvasta valmistettuja mikropalloja
ES2060102T3 (es) Productos para aplicacion cutanea, con efectos cosmeticos y/o terapeuticos.
FR2713635B1 (fr) Nouveaux composés propynyl bi-aromatiques, compositions pharmaceutiques et cosmétiques les contenant et utilisations.
CO4130178A1 (es) Composicion para el cuidado personal en forma de gel, que tiene propiedades viscoelasticas
BR0014836A (pt) Microcápsulas para a estabilização de produtos cosméticos, farmacêuticos ou alimentìcios
FR2710264B1 (fr) Utilisation pour le traitement des peaux mixtes d'une quantité efficace de substances actives.
TR199801501T1 (xx) Yeni form�lasyon.
PT1131039E (pt) Utilizacao de uma substancia que se liga ao receptor periferico das benzodiazepinas no tratamento de stresses cutaneos
FR2755965B1 (fr) Composes biaromatiques, compositions pharmaceutiques et cosmetiques les contenant et utilisations
MX9602973A (es) Uso de un antagonista de bradiquinina en una composicion, cosmetica, farmaceutica o dermatologica y la composicion obtenida.
DE69419981T2 (de) Retinoid enthaltendes Mittel
ATE303127T1 (de) Verwendung von mindestens einem irvingia gabonensis-extrakt in kosmetischen und/oder pharmazeutischen produkten
ATE143276T1 (de) Transdermales system mit gestufter wirkstoffabgabe und verwendung für die lokale oder systemische, kosmetische wirkstoffverabreichung
ATE52911T1 (de) Topische anwendung des 3-phenylacetylamino-2,6piperidindionszur behandlung von hautfalten und hyperpigmentierung.
FR2653015B1 (fr) Composition cosmetique ou pharmaceutique pour application topique contenant au moins un derive retinouide et au moins un derive de pyrimidine, son utilisation comme medicament et procede de traitement correspondant.
ATE401855T1 (de) Stabile hautbehandlungsmittel enthaltend ein retinoid und ein retinoid-boostersystem
WO1998038968A3 (de) Kosmetisches körperpflegepräparat das honig enthält und verfahren zu seiner herstellung
ATE77048T1 (de) Bioemulgatoren enthaltende kosmetische und pharmazeutische zusammensetzungen.
TR199901237T2 (xx) Bir tienilsiklohegzilamin t�revinin tedavide yeni uygulamas�.
ITCA930003A1 (it) Prodotto dermatologico per uso topico, relativo processo di produzione ed ulizzazione terapeutica nelle ustioni e patologie cutanee.
RU94008830A (ru) Основа для косметических средств
BR9702887A (pt) Processo de fabricação de produtos.
IT1282904B1 (it) Macchinario per l'esercizio dei muscoli facciali e per il miglioramento dell'aspetto estetico del viso
MX9605916A (es) Compuestos bioaromaticos que llevan un grupo adamantilo en para, composiciones farmaceuticos y cosmeticas que los contienen y utilizaciones.

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DE INT.CL.8: A61K 31/19, A61K 31/192, A61K 31/59, A61K 31/592, A61K 31/593, A91P 17/00, A61P 17/06, A61P 17/10, A61P 17/12

Ipc: A61K 31/19, A61K 31/192, A61K 31/39, A61K 31/592,

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 22/04/2009, OBSERVADAS AS CONDICOES LEGAIS.

B22O Other matters related to patents and certificates of addition of invention: legal action concerning patent

Free format text: INPI-52400.68489/2013 ORIGEM: JUIZO DA 001A VARA FEDERAL DE SAO PAULO PROCESSO NO 0017575-93.2013.4.03.6100 ACAO DE NULIDADE DE PATENTE AUTOR: INSTITUTO NACIONAL DA PROPRIEDADE INDUSTRIAL - INPI REU: GENENTECH, INC., CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA, PELE NOVA BIOTECNOLOGIA S/A E UNILEVER N.V.

B21B Extinction acc. art. 78, item ii - on waiver by the patentee, without prejudice to the rights of third parties

Free format text: SOLICITADA ATRAVES DA PETICAO 18130036473 (SP), DE 04/11/2013